| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |